BeOne Medicines
ONC
#614
Rank
S$54.06 B
Marketcap
S$477.92
Share price
-0.15%
Change (1 day)
20.47%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): S$6.17

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is S$6.12. In 2025 the company made an earnings per share (EPS) of S$3.47 an increase over its 2024 EPS that were of S-$7.94.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$6.1777.77%
2025S$3.47-143.75%
2024S-$7.94
2022S-$24.8028.21%
2021S-$19.34-19.96%
2020S-$24.1720.81%
2019S-$20.0031.52%
2018S-$15.21417.57%
2017S-$2.94-37.16%
2016S-$4.68158.95%
2015S-$1.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.34-105.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.21-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA